App aims to forecast seizures days in advance
NCT ID NCT07068919
First seen Oct 01, 2025 · Last updated Jun 19, 2026 · Updated 31 times
Summary
This study tests a mobile app called EPIDAY that uses daily symptom reports and machine learning to predict the risk of an epileptic seizure. Researchers will enroll 50 adults with focal epilepsy to see how accurate the app's daily predictions are in real life. The goal is to give people a warning so they can take precautions, not to cure or control the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Pitié-Salpêtrière, AP-HP
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.